Looking back, it becomes apparent that the stock may have found some technical support around $15.60. Just take a look at the chart and you'll see a big selloff down to about $16 back in November of last year, and a subsequent spike in demand for the shares shortly thereafter.
The recent dip has come on heavy volume, as volatility -- and questions over the credit cycle -- have rocked the markets and left the financials in bad shape all around.
Could we be looking at the beginning of a nice run-up for NMR? We can only hope. Take a look and see how the recent low (and our Trailing Stop) coincide almost perfectly with the stock's long-term support levels:

Good investing,
James
1 comment:
This is great analysis - and I think Bernanke's move could help banks the most. Peter443
Post a Comment